Prolonged remission in adult-onset Still's disease with etanercept.
Kumari
Rakesh
R
Uppal
Sukhbir S
SS
D000082:Acetaminophen / Q000627:therapeutic use; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008775:Methylprednisolone / Q000627:therapeutic use; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D012074:Remission Induction; D016706:Still's Disease, Adult-Onset / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D014147:Tramadol / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D018501:Antirheumatic Agents; D052246:Cyclooxygenase 2 Inhibitors; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D011993:Recombinant Fusion Proteins; D000082:Acetaminophen; D014147:Tramadol; D000068800:Etanercept; D008775:Methylprednisolone; D008727:Methotrexate